REPLACEMENT (TMVR)
Tendyne™ TMVR System is first-in-class technology designed
to eliminate Mitral Regurgitation (MR), offering selected patients
with MR (≥ grade 3) a novel option for mitral valve replacement.
Now indicated for patients with severe MAC
Tendyne is now indicated for patients with severe Mitral Annular Calcification (MAC). This indication has received the CE Mark approval and allows us to offer Tendyne to a patient population with no alternative treatments, significantly improving their quality of life.
Hear firsthand from leading experts, Alison Duncan, Paolo Denti, Hendrik Ruge, and Christopher Klein as they provide their insights on Tendyne.
LEARN MORE:
TV